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a b s t r a c t
Neuroendocrine tumor (NET) is detected in the examinationof polypectomymaterial, presenting as rectal
polyp. Since this is a rare case, we aimed to summarize the approach to rectal NET’s.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/4.0/).
Introduction
Neuroendocrine tumors originate from neuroendocrine cells
of endodermal origin, spreading along the gastrointestinal tract.
Prevalence of neuroendocrine tumor is around 35/100,000, includ-
ing all types. They are most frequently observed in gastrointestinal
system (GIS) [67%]. In GIS, they are most frequently observed at
ileum [34%] and secondly at rectum [27.4%] [1–2]. Neuroendocrine
tumors excrete various peptide hormones such as chromogranin
A, pancreatic polypeptide, calcitonin and substance P, which may
be biologically active and biological amines like neuron speciﬁc
enolase, serotonin,5- hydroxytryptamine are under the control of
autonomic nervous system. Most of the NET’s express chromo-
granin A and synaptophysin.
Rectal NETs compose 1–2% of all rectal tumors, and gener-
ally demonstrate benign clinical proﬁle. The annual incidence in
United States of America is 0.93/100,000. Prevalence of rectal NETs
is around 5.1/100,000. Tumors with size less than one centime-
ter have a low risk for metastasis. This risk increases to 60–80%
at tumors with size greater than 2 cm. According to the classiﬁ-
cation by World Health Organization (W.H.O) in 2010, all NET’s
were considered as if they had malign potential. Proliferation index
(ki-67) and mitotic count were taken as basis. Accordingly, Grade
was speciﬁed as G1≤2%, G2 3–20%, and G3>20%. Mitotic count
was indicated as G1<2, G2 2–20, G3>20 at each 10 high power
ﬁelds (/10HPF). TNM classiﬁcation was indicated as T1a<1 cm–,
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T1b 1–2 cm–, and T2>2 cm+according to muscularis propria
invasion. 5-year survival is 87% in localized disease, and 25% in
presence of distant metastasis [1–5].
Presentation of case
A 82-year old female patient applied to our hospital with the
complaint of rectal bleeding. General condition of the patient
deﬁnedwell andher vital signswerewithin thenormal range (Arte-
rial tension: 120/80mmHg, pulse: 86/min). Her hemogram values
(WBC: 7.63K/uL, Hb:11.6 g/dL, plt:217K/uL.) and biochemical tests
were normal. In colonoscopy, sessile polyp with diameter of 1.3 cm
and internal hemorrhoid were detected at rectum at 15th cm
(Illustration 1). There was no other pathology in the entire parts
of the colon. In pathological examination of polypectomy material,
Ki-67 index was detected as 3%, mitotic count was detected as <2,
and NET, invading muscularis propria, was detected (Illustrations
2 and 3). It was determined as Grade G2, T2. In whole-abdomen
and thoracic computerized tomography (CT), no distant metasta-
sis was detected. Patient was referred to surgery for resection. Low
anterior resection was performed to the patient. Surgical margins
were tumor free. Patient was controlled in the outpatient clinic in
the postoperative ﬁrst month and scheduled for monitoring with
annual colonoscopy and appropriate imaging methods.
Discussion
Rate of rectal NET detection increases in the recent years.
Increased awareness of both clinicians and pathologists may play
http://dx.doi.org/10.1016/j.ijscr.2015.01.031
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Illustration 1. Endoscopic appearence.
Illustration 2. Hematoxylin& eosin appearance.
Illustration 3. Ki-67 appearance.
a role in this increase. These tumors are mostly asymptomatic
and present as polyps in colonoscopies. A retrospective cohort
study that evaluated 85 patients with rectal nets revealed that
at the time of diagnosis 60–90% of this lesions are detected as
small as 1 cm instantly. 46 [54%] of these patients are treated with
endoscopic resection, 31 [36%] of them are treated with surgi-
cal resection and 8 [9%] are treated medically. Thirty-one patients
[36%] underwent surgical resection; of these, 23 [74%] underwent
transanal excision or transanal endoscopic microsurgery (TEM), 6
[19%] underwent low anterior resection, and 2 [6%] underwent
abdominoperineal resection [3] . Although the ones with size
less than one centimeter generally have a benign clinical course,
metastasis may also be observed rarely. Endoscopic resection or
disection are sufﬁcient for treatment of tumors. Transanal exci-
sion should be considered when margins of endoscopic resection
are positive. Treatment of NETs between 1 and 1.9 cm in diam-
eter are controversial. It is difﬁcult to predict the behavior of
these tumors. Metastasis rate is between 4 and 30%. While some
authors suggests rectal resection, the others advocate transanal
excision or transanal endoscopic microsurgery in selected cases.
Also, invasion of the tumor is another factor that determines the
treatment decision. Distance between tumor and anal canal and
tumor’s potential to cause obstruction are also very important
factors while deciding the treatment. Tumors, not invading mus-
cularis propria, are treated by endoscopic resection or endoscopic
dissection, and tumors invading are treated by surgical resection, if
no distant metastasis is present. Tumors with size greater than two
centimeters may have an aggressive course and poor prognosis.
Metastasis can be detected 70–80% during follow-up or at the time
of diagnosis. Abdominoperineal resection or low anterior resection
are the necessary treatments for these tumors. Somatostatin recep-
tor analogs are used in immunotherapy at patients with distant
metastasis. However, presence of 5 distinct subtypes of somato-
statin receptors creates problems in treatment. IFN (interferon) is
considered to be a cost-effective treatment. PRRT (peptide receptor
radio-nucleotide therapy) appears to be a key strategy in terms of
treatment and imaging. In addition to these classical agents, new
agents, targeting incretin (GLP-1R; GIPR) and G-protein coupled
receptors, are used in treatment [3–6]. During follow-up it was
suggested that rectosigmoidoscopy should be performed once in
6 months for 2 years and colonoscopy with imaging techniques
once in a year. Imaging methods include abdominopelvic com-
puted tomography, endoscopic ultrasonography, rectal MRI, and
octreotide imaging (somatostatin receptor scintigraphy).
Conclusion
Rectal neuroendocrine tumors are usually seen as one subep-
ithelial nodules as well as polyps and lesions can be seen in the
form of ulcers. WHO staging should be performed to determine an
appropriate treatment approach according to the 2010 guidelines.
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